Advertisements


Takeda CEO sees path to survival in Shire takeover, Bloomberg says

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 16th, 2018

Takeda gets Japanese approval for Shire takeover, awaits EU nod

On Thursday, Takeda Pharmaceutical Co. Ltd. said that Japan's Fair Trade Commission has approved its $62 billion bid to acquire the second-largest biotech employer in Massachusetts, Shire Pharmaceuticals plc. According to Reuters, the deal has alre.....»»

Category: topSource: bizjournalsOct 18th, 2018

Takeda"s $62 billion Shire bid faces November 6 EU antitrust deadline

EU antitrust regulators will decide by Nov. 6 whether to allow Japanese drugmaker Takeda Pharmaceutical's $62-billion takeover of London-listed Shire Plc , the European Commission said on Friday......»»

Category: topSource: reutersSep 28th, 2018

Top Takeda investor "skeptical" about Shire takeover bid, Sunday Times reports

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 24th, 2018

Takeda said to mull sale of Shire eye drug to cut debt, Bloomberg reports

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 13th, 2018

Takeda weighs sale of Shire"s eye care business to cut debt: Bloomberg

Japan's Takeda Pharmaceutical is considering selling Shire Plc's eye care business once it closes its $62 billion purchase of the London-listed drugmaker, as it looks to cut the debt raised to fund the deal, Bloomberg reported on Thursday......»»

Category: topSource: reutersSep 13th, 2018

The Fed"s new interest-rate path could have the US staring at a recession by the end of next year

Bloomberg The Fed hiked rates Wednesday and said it sees two more increases this year, for a total of four. It also sees three rate hikes in 2019. The central bank .....»»

Category: topSource: businessinsiderJun 14th, 2018

Takeda global ambitions grow after Shire takeover

Takeda Pharmaceutical hopes that their $62 billion deal to purchase Shire will make them a global bio-pharmaceutical leader. But as Silvia Antonioli reports, it comes with a heavy debt burden......»»

Category: videoSource: reutersMay 9th, 2018

Takeda/Shire transaction shows path for consolidation, says Leerink

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 9th, 2018

Takeda to takeover bigger rival Shire in $62bln deal

Takeda Pharmaceutical agrees to buy London-listed Shire for 45.3 billion pounds ($61.5.....»»

Category: topSource: usatodayMay 8th, 2018

Takeda to takeover bigger rival Shire in $62bln deal

Takeda Pharmaceutical agrees to buy London-listed Shire for 45.3 billion pounds ($61.50 billion) after the Japanese company raises the amount of cash in its offer to secure a recommendation. Silvia Antonioli reports......»»

Category: videoSource: reutersMay 8th, 2018

Japan"s biggest ever deal: Takeda buys Shire for $62 billion

Japanese drugmaker Takeda has reached a $62 billion deal to buy rival Shire in the world's biggest takeover so far this year......»»

Category: topSource: cnnMay 8th, 2018

Japan"s Takeda seals $62 billion takeover of Adderall maker Shire

Reuters J.....»»

Category: topSource: businessinsiderMay 8th, 2018

Takeda Finally Inks a Deal to Buy Shire in One of the Biggest Pharma Takeovers Ever

It's the largest-ever international takeover by any Japanese company, at a value of $62 billion. Japan’s Takeda Pharmaceutical is about to become.....»»

Category: europeSource: fortuneMay 8th, 2018

Japan"s Takeda agrees $62 billion takeover of Shire

LONDON (Reuters) - Takeda Pharmaceutical agreed to buy London-listed Shire for 45.3 billion pounds ($61.50 billion) on Tuesday after the Japanese company raised the amount of cash in its offer to $30.33 to secure a recommendation......»»

Category: topSource: reutersMay 8th, 2018

Shire rallies 4.3% after Takeda takeover deal

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchMay 8th, 2018

Takeda near agreement to acquire Shire, Bloomberg reports

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 7th, 2018

Takeda sweetens the pill for Shire with $64 billion takeover offer

Rare disease specialist Shire says it is willing to recommend a sweetened $64 billion offer from Japan's Takeda Pharmaceutical Co to shareholders, in what would be the biggest acquisition of a drug company this year. Silvia Antonioli reports......»»

Category: videoSource: reutersApr 25th, 2018

Shire Opens Door to $64 Billion Sale to Japan"s Takeda

Takeda moved closer to securing a $64 billion takeover of Shire after the target said it was willing to recommend that shareholders accept the Japanese firm’s latest proposal......»»

Category: smallbizSource: wsjApr 25th, 2018

Shire rises 2.7% as drug maker supports Takeda"s revised takeover bid

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchApr 25th, 2018

Shire Inches Closer to Accepting Takeda"s $64 Billion Takeover

Shire said it is willing to recommend that shareholders accept Takeda Pharmaceutical’s last-ditch $64 billion takeover bid and extended the deadline for a possible deal......»»

Category: smallbizSource: wsjApr 25th, 2018